vs
Organogenesis Holdings Inc.（ORGO）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
Organogenesis Holdings Inc.的季度营收约是ROGERS CORP的1.1倍（$225.6M vs $200.5M），Organogenesis Holdings Inc.净利率更高（19.4% vs 2.2%，领先17.1%），Organogenesis Holdings Inc.同比增速更快（78.1% vs 5.2%），Organogenesis Holdings Inc.自由现金流更多（$34.8M vs $1.1M），过去两年Organogenesis Holdings Inc.的营收复合增速更高（43.2% vs -3.3%）
Organogenesis Holdings Inc.是一家领先的再生医学企业，专注于开发、生产用于伤口护理、外科修复、运动医学和皮肤病领域的先进治疗产品，主要服务美国及部分国际市场的医疗机构与患者，提供经临床验证的医疗解决方案。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
ORGO vs ROG — 直观对比
营收规模更大
ORGO
是对方的1.1倍
$200.5M
营收增速更快
ORGO
高出72.9%
5.2%
净利率更高
ORGO
高出17.1%
2.2%
自由现金流更多
ORGO
多$33.7M
$1.1M
两年增速更快
ORGO
近两年复合增速
-3.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $225.6M | $200.5M |
| 净利润 | $43.7M | $4.5M |
| 毛利率 | — | 32.2% |
| 营业利润率 | 28.1% | — |
| 净利率 | 19.4% | 2.2% |
| 营收同比 | 78.1% | 5.2% |
| 净利润同比 | 469.5% | 421.4% |
| 每股收益（稀释后） | $0.31 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ORGOROG
| Q1 26 | — | $200.5M | ||
| Q4 25 | $225.6M | $201.5M | ||
| Q3 25 | $150.9M | $216.0M | ||
| Q2 25 | $101.0M | $202.8M | ||
| Q1 25 | $86.7M | $190.5M | ||
| Q4 24 | $126.7M | $192.2M | ||
| Q3 24 | $115.2M | $210.3M | ||
| Q2 24 | $130.2M | $214.2M |
净利润ORGOROG
| Q1 26 | — | $4.5M | ||
| Q4 25 | $43.7M | $4.6M | ||
| Q3 25 | $21.6M | $8.6M | ||
| Q2 25 | $-9.4M | $-73.6M | ||
| Q1 25 | $-18.8M | $-1.4M | ||
| Q4 24 | $7.7M | $-500.0K | ||
| Q3 24 | $12.3M | $10.7M | ||
| Q2 24 | $-17.0M | $8.1M |
毛利率ORGOROG
| Q1 26 | — | 32.2% | ||
| Q4 25 | — | 31.5% | ||
| Q3 25 | — | 33.5% | ||
| Q2 25 | — | 31.6% | ||
| Q1 25 | 72.6% | 29.9% | ||
| Q4 24 | 75.5% | 32.1% | ||
| Q3 24 | 76.7% | 35.2% | ||
| Q2 24 | 77.6% | 34.1% |
营业利润率ORGOROG
| Q1 26 | — | — | ||
| Q4 25 | 28.1% | 3.5% | ||
| Q3 25 | 13.7% | 7.3% | ||
| Q2 25 | -12.5% | -33.3% | ||
| Q1 25 | -30.9% | -0.2% | ||
| Q4 24 | 8.1% | -6.6% | ||
| Q3 24 | 5.4% | 6.9% | ||
| Q2 24 | -10.7% | 5.3% |
净利率ORGOROG
| Q1 26 | — | 2.2% | ||
| Q4 25 | 19.4% | 2.3% | ||
| Q3 25 | 14.3% | 4.0% | ||
| Q2 25 | -9.3% | -36.3% | ||
| Q1 25 | -21.7% | -0.7% | ||
| Q4 24 | 6.1% | -0.3% | ||
| Q3 24 | 10.7% | 5.1% | ||
| Q2 24 | -13.1% | 3.8% |
每股收益（稀释后）ORGOROG
| Q1 26 | — | $0.25 | ||
| Q4 25 | $0.31 | $0.20 | ||
| Q3 25 | $0.11 | $0.48 | ||
| Q2 25 | $-0.10 | $-4.00 | ||
| Q1 25 | $-0.17 | $-0.08 | ||
| Q4 24 | $0.05 | $-0.04 | ||
| Q3 24 | $0.09 | $0.58 | ||
| Q2 24 | $-0.13 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $93.7M | $195.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $300.1M | $1.2B |
| 总资产 | $598.7M | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ORGOROG
| Q1 26 | — | $195.8M | ||
| Q4 25 | $93.7M | $197.0M | ||
| Q3 25 | $63.7M | $167.8M | ||
| Q2 25 | $73.1M | $157.2M | ||
| Q1 25 | $110.0M | $175.6M | ||
| Q4 24 | $135.6M | $159.8M | ||
| Q3 24 | $94.3M | $146.4M | ||
| Q2 24 | $89.9M | $119.9M |
总债务ORGOROG
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $62.3M | — | ||
| Q2 24 | $63.8M | — |
股东权益ORGOROG
| Q1 26 | — | $1.2B | ||
| Q4 25 | $300.1M | $1.2B | ||
| Q3 25 | $255.1M | $1.2B | ||
| Q2 25 | $233.2M | $1.2B | ||
| Q1 25 | $242.9M | $1.3B | ||
| Q4 24 | $262.9M | $1.3B | ||
| Q3 24 | $278.5M | $1.3B | ||
| Q2 24 | $263.5M | $1.3B |
总资产ORGOROG
| Q1 26 | — | $1.4B | ||
| Q4 25 | $598.7M | $1.4B | ||
| Q3 25 | $509.8M | $1.4B | ||
| Q2 25 | $461.1M | $1.5B | ||
| Q1 25 | $467.4M | $1.5B | ||
| Q4 24 | $497.9M | $1.5B | ||
| Q3 24 | $446.3M | $1.5B | ||
| Q2 24 | $443.2M | $1.5B |
负债/权益比ORGOROG
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.22× | — | ||
| Q2 24 | 0.24× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $39.4M | $5.8M |
| 自由现金流经营现金流 - 资本支出 | $34.8M | $1.1M |
| 自由现金流率自由现金流/营收 | 15.4% | 0.5% |
| 资本支出强度资本支出/营收 | 2.1% | 2.3% |
| 现金转化率经营现金流/净利润 | 0.90× | 1.29× |
| 过去12个月自由现金流最近4个季度 | $-24.5M | $70.1M |
8季度趋势，按日历期对齐
经营现金流ORGOROG
| Q1 26 | — | $5.8M | ||
| Q4 25 | $39.4M | $46.9M | ||
| Q3 25 | $3.1M | $28.9M | ||
| Q2 25 | $-32.9M | $13.7M | ||
| Q1 25 | $-19.9M | $11.7M | ||
| Q4 24 | $10.9M | $33.7M | ||
| Q3 24 | $8.7M | $42.4M | ||
| Q2 24 | $4.7M | $22.9M |
自由现金流ORGOROG
| Q1 26 | — | $1.1M | ||
| Q4 25 | $34.8M | $42.2M | ||
| Q3 25 | $844.0K | $21.2M | ||
| Q2 25 | $-36.5M | $5.6M | ||
| Q1 25 | $-23.6M | $2.1M | ||
| Q4 24 | $7.6M | $18.3M | ||
| Q3 24 | $6.1M | $25.2M | ||
| Q2 24 | $2.9M | $8.8M |
自由现金流率ORGOROG
| Q1 26 | — | 0.5% | ||
| Q4 25 | 15.4% | 20.9% | ||
| Q3 25 | 0.6% | 9.8% | ||
| Q2 25 | -36.1% | 2.8% | ||
| Q1 25 | -27.2% | 1.1% | ||
| Q4 24 | 6.0% | 9.5% | ||
| Q3 24 | 5.3% | 12.0% | ||
| Q2 24 | 2.2% | 4.1% |
资本支出强度ORGOROG
| Q1 26 | — | 2.3% | ||
| Q4 25 | 2.1% | 2.3% | ||
| Q3 25 | 1.5% | 3.6% | ||
| Q2 25 | 3.6% | 4.0% | ||
| Q1 25 | 4.2% | 5.0% | ||
| Q4 24 | 2.7% | 8.0% | ||
| Q3 24 | 2.2% | 8.2% | ||
| Q2 24 | 1.4% | 6.6% |
现金转化率ORGOROG
| Q1 26 | — | 1.29× | ||
| Q4 25 | 0.90× | 10.20× | ||
| Q3 25 | 0.14× | 3.36× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.43× | — | ||
| Q3 24 | 0.71× | 3.96× | ||
| Q2 24 | — | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
